Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival (Q34021957)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival
scientific article

    Statements

    title
    Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    author name string
    Joaquim Bellmunt
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Sylvie Négrier
    series ordinal
    3
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Emilio Bajetta
    series ordinal
    4
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Bohuslav Melichar
    series ordinal
    5
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Sergio Bracarda
    series ordinal
    6
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Alain Ravaud
    series ordinal
    7
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Sophie Golding
    series ordinal
    8
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Sangeeta Jethwa
    series ordinal
    9
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    Vesna Sneller
    series ordinal
    10
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017
    page(s)
    2144-2150
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    20368553
    retrieved
    30 July 2017

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q34021957&oldid=1618954324"